# US 2012/0258550 A1 · Regulation of autophagy pathway phosphorylation and uses thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0258550 A1
- Document ID: US20120258550A1
- Status: Published application
- Kind: A1
- Application number: 13/438,770
- Filed: 2012-04-03
- Published: 2012-10-11
- Earliest claimed: 2008-07-18
- Assignees: Abgent
- Inventors: Chun Wu; John A. Mountzouris; Bingren Hu; Chunli Liu
- Web page: https://patentgrep.com/patent/US20120258550A1

## CPC

- C07K 16/44: against material not provided for elsewhere {, e.g. haptens, metals, DNA, RNA, amino acids}
- A61P 37/02: Immunomodulators
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C07K 5/1008: {the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala}
- C07K 5/101: {the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu}
- C07K 5/1013: {the side chain containing O or S as heteroatoms, e.g. Cys, Ser}
- C07K 5/1016: {and aromatic or cycloaliphatic}
- C07K 5/1019: {with the first amino acid being basic}
- C07K 5/1021: {with the first amino acid being acidic}
- C07K 5/1024: {with the first amino acid being heterocyclic}
- C07K 5/1027: {containing heteroatoms different from O, S, or N}
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The invention relates to polypeptides and proteins known to function in the autophagy pathway that have novel phosphorylation sites. The invention also relates to antibodies specific to these polypeptides and proteins that are phosphorylated or not phosphorylated at novel phosphorylated sites. The invention also relates to methods of producing these antibodies and use of these antibodies in the treatment of diseases related to autophagocytosis.

## Claims

### Claim 1

An isolated autophagy peptide comprising an amino acid sequence selected from the group consisting of sequences set forth in Table 1, wherein the x residue is nonphosphorylated or phosphorylated serine, threonine, or tyrosine, and with the proviso that the peptide is not a full-length autophagy protein.

### Claim 2 (depends on 1)

An isolated autophagy peptide of claim 1 wherein the peptide does not comprise a sequence set forth in Table 2.

### Claim 3 (depends on 1)

The isolated autophagy peptide of claim 1, which comprises an amino acid sequence selected from the group consisting of the sequences set forth in Table 3.

### Claim 4 (depends on 1)

The isolated autophagy peptide of claim 1, which comprises an amino acid sequence selected from the group consisting of sequences set forth in Table 1.

### Claim 5 (depends on 4)

The isolated autophagy peptide of claim 4, wherein the x residue is nonphosphorylated serine, threonine, or tyrosine.

### Claim 6 (depends on 1)

The isolated autophagy peptide of claim 1, wherein the x residue is phosphorylated serine, threonine, or tyrosine.

### Claim 7 (depends on 1)

A method for producing an antibody to an autophagy polypeptide, which method comprises:
(a) introducing an isolated autophagy peptide of claim 1 to a mammal in an amount sufficient to produce an antibody to said autophagy peptide; and
(b) recovering said antibody from said mammal.

### Claim 8 (depends on 7)

The method of claim 7, wherein the x residue in the isolated autophagy peptide is nonphosphorylated serine, threonine, or tyrosine and the method is used to produce an antibody to a nonphosphorylated autophagy polypeptide.

### Claim 9 (depends on 7)

The method of claim 7, wherein the x residue in the isolated autophagy peptide is phosphorylated serine, threonine, or tyrosine and the method is used to produce an antibody to a phosphorylated autophagy polypeptide.

### Claim 10

A method for detecting an autophagy protein or fragment comprising an amino acid sequence set forth in Table 4, wherein the x residue is phosphorylated or nonphosphorylated serine, threonine, or tyrosine in a sample, which method comprises:
(a) contacting a sample containing or suspected of containing an autophagy protein or fragment comprising the amino acid sequence set forth in Table 4, wherein the x residue is phosphorylated or nonphosphorylated serine, threonine, or tyrosine, with an isolated antibody that specifically binds to an epitope that comprises the amino acid residue x in the amino acid sequence set forth in Table 4, wherein the x residue is phosphorylated or nonphosphorylated serine, threonine, or tyrosine; and
(b) assessing a complex formed between said autophagy protein or fragment, if present in said sample, and said antibody, to determine the presence, absence and/or amount of said autophagy protein or fragment in said sample.

### Claim 11 (depends on 10)

The method of claim 10, wherein the epitope comprises the amino acid residue x in the amino acid sequence set forth in Table 4 and an amino acid residue of the autophagy protein that is outside the amino acid sequence set forth in Table 4.

### Claim 12 (depends on 10)

The method of claim 10, wherein the epitope comprises the amino acid residue x in the amino acid sequence set forth in Table 4 and amino acid residues of the autophagy protein that are outside the amino acid sequence set forth in Table 4.

### Claim 13 (depends on 10)

The method of claim 10, wherein the epitope is comprised in the amino acid sequence set forth in Table 4.

### Claim 14 (depends on 10)

The method of claim 10, wherein the epitope is comprised in an amino acid sequence set forth in Table 3.

### Claim 15 (depends on 10)

The method of claim 10, wherein the epitope is comprised in an amino acid sequence selected from the sequence set forth in Table 1.

### Claim 16 (depends on 10)

The method of claim 10, wherein the isolated antibody specifically binds to the epitope that comprises the x residue in the amino acid sequence set forth in Table 4, wherein the x residue is nonphosphorylated serine, threonine, or tyrosine.

### Claim 17 (depends on 10)

The method of claim 10, wherein the isolated antibody specifically binds to the epitope that comprises the x residue in the amino acid sequence set forth in Table 4, wherein the x residue is phosphorylated serine, threonine, or tyrosine.

### Claim 18 (depends on 10)

The method of claim 10, wherein the isolated antibody specifically binds to an epitope comprised in the amino acid sequence set forth in Table 4, wherein the x residue is nonphosphorylated serine, threonine, or tyrosine, but does not specifically bind to an epitope comprised in the amino acid sequence set forth in Table 4 wherein the x residue is phosphorylated serine, threonine, or tyrosine.

### Claim 19 (depends on 10)

The method of claim 10, wherein the isolated antibody specifically binds to an epitope comprised in the amino acid sequence set forth in Table 4, wherein the x residue is phosphorylated serine, threonine, or tyrosine, but does not specifically bind to an epitope comprised in the amino acid sequence set forth in Table 4 wherein the x residue is nonphosphorylated serine, threonine, or tyrosine.
